Literature DB >> 30401482

Conbercept for Treatment of Neovascular Age-related Macular Degeneration: Results of the Randomized Phase 3 Phoenix Study.

Dan Călugăru1, Mihai Călugăru1.   

Abstract

Mesh:

Substances:

Year:  2018        PMID: 30401482     DOI: 10.1016/j.ajo.2018.09.027

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


× No keyword cloud information.
  2 in total

1.  Comment on: Real-world outcomes of two-year Conbercept therapy for diabetic macular edema.

Authors:  Dan Călugăru; Mihai Călugăru
Journal:  Int J Ophthalmol       Date:  2022-04-18       Impact factor: 1.779

Review 2.  Age-Related Macular Degeneration Revisited: From Pathology and Cellular Stress to Potential Therapies.

Authors:  Majda Hadziahmetovic; Goldis Malek
Journal:  Front Cell Dev Biol       Date:  2021-01-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.